Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Business Leaders  >  Business Leaders Biography

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors 
HomeAll newsMost read newsBusiness Leaders Biography
Portrait de Scott Andrew Smith
Age : 56
Public asset : 4,943,419 USD
Linked companies : Spring Bank Pharmaceuticals Inc - Titan Pharmaceuticals, Inc.
Summary 
Currently, Scott Andrew Smith occupies the position of President at BioAtla LLC.

He is also on the board of 5 other companies.

In his past career Mr. Smith was President & Chief Operating Officer for Celgene Corp., General Manager at Biovail Pharmaceuticals Canada, Head-South East Asia Region at Parke Davis Ltd., Vice President & General Manager at Biovail Pharmaceuticals LLC, Vice President at Pharmacia Canada, Inc., Vice President-Marketing of Pharmacia SAS and Vice President-Sales at Pharmacia Corp.

Mr. Smith received an undergraduate degree from the University of Western Ontario and a graduate degree from Thunderbird School of Global Management.


Current positions of Scott Andrew Smith 
NameTitle Since
Spring Bank Pharmaceuticals Inc
(Biotechnology & Medical Research)
Independent Director 2018
Titan Pharmaceuticals, Inc.
(Pharmaceuticals)
Independent Director 2017
BioAtla LLC President 2018
Biotechnology Innovation Organization Director 2017
GNS Healthcare, Inc. Director 2018
Triumvira Immunologics, Inc. Director 2018


Holdings of Scott Andrew Smith 
NameEquities%Valuation
Celgene Corporation (CELG)
Pharmaceuticals
52,3390.0074%4,943,419 USD
Titan Pharmaceuticals, Inc. (TTNP)
Pharmaceuticals
00.0000%0 USD
Spring Bank Pharmaceuticals Inc (SBPH)
Biotechnology & Medical Research
00.0000%0 USD


Scott Andrew Smith: Personal Network 


Most Read News 
09/20JACK MA : Xinhua
RE
09/24JEAN-CHARLES NAOURI : Casino rejects merger approach that Carrefour denies making
RE
09/20NICANDRO DURANTE : British American Tobacco CEO Nicandro Durante to Retire
DJ
09/24MICHAEL DELL : sources
RE
09/21DAVID BONDERMAN : Frustrated Ryanair investors target chairman after year of strikes
RE
09/21MICHAEL O'LEARY : Ryanair's O'Leary says reluctant to commit to five more years as CEO
RE
09/20RICHARD LI : Minneapolis prosecutors weighing evidence in JD.com CEO case
RE
09/19NICANDRO DURANTE : British American Tobacco CEO Durante Expected to Leave -Sky News
DJ
09/19ELON MUSK : U.S. Justice Department probes Musk statement on taking Tesla private
RE
09/19GARY COHN : Wells Fargo Board Members Had Approached Gary Cohn for CEO Role-NY Post
DJ
More news


© 2018 People and Ownership :   
Advertisement
Scott Andrew Smith : Connections 
Southeast BIO
JT Pharmaceuticals
iTeos Therapeutics SA
FirstString Research, Inc.
Massachusetts Biotechnology Council
South Carolina Coastal Conservation League, Inc.
NovaDigm Therapeutics, Inc.
Cantex Pharmaceuticals, Inc.
The Barn for the Poorest of the Poor
Burrage Capital Management LLC
FORMA Therapeutics, Inc.
Mpm Capital LLC



Popular Business Leaders 
Marc Benioff Jeff Bezos Lloyd Blankfein Martin Bouygues Warren Buffett Tim Cook Elmar Degenhart Michael Dell Oleg Deripaska Jamie Dimon Nicandro Durante John Edwards David Einhorn Bill Gates David Henry Heinrich Hiesinger Carl Icahn Charles Koch Ulrich Lehner Robin Li Daniel Loeb Jack Ma Sergio Marchionne Lakshmi Mittal Leslie Moonves Dennis Muilenburg Rupert Murdoch Elon Musk Peter Nicholas Xavier Niel Indra Nooyi Michael O'leary James Packer John Paulson Thomas Rabe Sumner Redstone Alexandre Ricard Wilbur Ross Sheryl Sandberg Charles Schwab Masayoshi Son Martin Sorrell Rupert Stadler Tidjane Thiam François Villeroy De Galhau An Wang Martin Winterkorn Dieter Zetsche Mark Zuckerberg
A-Z Business Leaders